Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...

ALBAWABA - Famous trapeze artist Marina B tragically died at 27 after falling 16 feet to the ground in front of the audience during a circus performance in Germany. Marina Barceló was performing at a ...

Spanish trapeze artist Marina B. has died after a tragic accident during a circus performance. She was 27. Marina (real name Marina Barceló) was performing at Circus Paul Busch in Bautzen, Germany, on ...

SINGAPORE – Some taxi rides from Marina Bay Cruise Centre Singapore will cost more from Oct 1. Transport operators ComfortDelGro and Strides Premier said in separate Facebook posts on Sept 24 that ...

FORT PIERCE, Fla. (CBS12) — The city of Fort Pierce is working on a project downtown called Marina Square. According to the city website, the plan is to develop a public space where various events can ...

Arbutus Biopharma (ABUS) is a clinical-stage biotech focused on LNP technology, with value now hinging on ongoing patent litigation against Moderna and Pfizer/BioNTech. Recent management changes and ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Arbutus ...

Fresh from rocking the festival circuit at Bonnaroo, Lollapalooza, Osheaga and Outside Lands, Marina launched her Princess of Power Tour on Saturday, Sept. 6, at Showbox SoDo in Seattle. The 21-city ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Arbutus Biopharma (ABUS) is a stock that can certainly grab the ...

Florida Keys fishing captain finds 55 pounds of cocaine near Square Grouper Marina. Authorities handed over the suspected drugs to U.S. Border Patrol. MCSO A sack of “square groupers,” more than 50 ...

WARMINSTER, Pa. (AP) — WARMINSTER, Pa. (AP) — Arbutus Biopharma Corp. (ABUS) on Wednesday reported second-quarter net income of $2.5 million, after reporting a loss in the same period a year earlier.

Arbutus Biopharma had made no secret of its plans to step up its work on imdusiran. Now, the company has regained the China rights to the potential functional cure for hepatitis B. China-based Qilu ...